Our current focus encompasses products that allow both safeguarding integrity of bio-samples and efficient isolation of circulating biomarkers from biological samples for human genetic research including cancer genomic studies and non-invasive prenatal testing (NIPT).

Our core platform allows efficiency in the nucleic acids sequencing methods including Sanger and Next Generation Sequencing (NGS) in both manual and automated workflow.

Our corporate mission is to help our customers generate quality data faster at an affordable cost.